BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 24140063)

  • 1. C-Myc negatively controls the tumor suppressor PTEN by upregulating miR-26a in glioblastoma multiforme cells.
    Guo P; Nie Q; Lan J; Ge J; Qiu Y; Mao Q
    Biochem Biophys Res Commun; 2013 Nov; 441(1):186-90. PubMed ID: 24140063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-17 inhibitor suppressed osteosarcoma tumor growth and metastasis via increasing PTEN expression.
    Gao Y; Luo LH; Li S; Yang C
    Biochem Biophys Res Commun; 2014 Feb; 444(2):230-4. PubMed ID: 24462867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiRNA-26a inhibits myocardial infarction-induced apoptosis by targeting PTEN via JAK/STAT pathways.
    Wang J; Feng Q; Liang D; Shi J
    Cells Dev; 2021 Mar; 165():203661. PubMed ID: 33993982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulation of miR-153 promotes cell proliferation via downregulation of the PTEN tumor suppressor gene in human prostate cancer.
    Wu Z; He B; He J; Mao X
    Prostate; 2013 May; 73(6):596-604. PubMed ID: 23060044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Sox2:miR-486-5p Axis Regulates Survival of GBM Cells by Inhibiting Tumor Suppressor Networks.
    Lopez-Bertoni H; Kotchetkov IS; Mihelson N; Lal B; Rui Y; Ames H; Lugo-Fagundo M; Guerrero-Cazares H; Quiñones-Hinojosa A; Green JJ; Laterra J
    Cancer Res; 2020 Apr; 80(8):1644-1655. PubMed ID: 32094299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation.
    Zheng H; Ying H; Yan H; Kimmelman AC; Hiller DJ; Chen AJ; Perry SR; Tonon G; Chu GC; Ding Z; Stommel JM; Dunn KL; Wiedemeyer R; You MJ; Brennan C; Wang YA; Ligon KL; Wong WH; Chin L; DePinho RA
    Nature; 2008 Oct; 455(7216):1129-33. PubMed ID: 18948956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-221 targeting PI3-K/Akt signaling axis induces cell proliferation and BCNU resistance in human glioblastoma.
    Xie Q; Yan Y; Huang Z; Zhong X; Huang L
    Neuropathology; 2014 Oct; 34(5):455-64. PubMed ID: 24780067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MYC stimulates EZH2 expression by repression of its negative regulator miR-26a.
    Sander S; Bullinger L; Klapproth K; Fiedler K; Kestler HA; Barth TF; Möller P; Stilgenbauer S; Pollack JR; Wirth T
    Blood; 2008 Nov; 112(10):4202-12. PubMed ID: 18713946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of tumorigenicity by microRNA-138 through inhibition of EZH2-CDK4/6-pRb-E2F1 signal loop in glioblastoma multiforme.
    Qiu S; Huang D; Yin D; Li F; Li X; Kung HF; Peng Y
    Biochim Biophys Acta; 2013 Oct; 1832(10):1697-707. PubMed ID: 23707559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gliomagenesis arising from Pten- and Ink4a/Arf-deficient neural progenitor cells is mediated by the p53-Fbxw7/Cdc4 pathway, which controls c-Myc.
    Kim HS; Woolard K; Lai C; Bauer PO; Maric D; Song H; Li A; Kotliarova S; Zhang W; Fine HA
    Cancer Res; 2012 Nov; 72(22):6065-75. PubMed ID: 22986743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The over-expression of miR-34a fails to block DoHH2 lymphoma cell proliferation by reducing p53 via c-MYC down-regulation.
    Rizzo M; Mariani L; Cavallini S; Simili M; Rainaldi G
    Nucleic Acid Ther; 2012 Aug; 22(4):283-8. PubMed ID: 22830357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-22 forms a regulatory loop in PTEN/AKT pathway and modulates signaling kinetics.
    Bar N; Dikstein R
    PLoS One; 2010 May; 5(5):e10859. PubMed ID: 20523723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-124 inhibits the growth of glioblastoma through the downregulation of SOS1.
    Lv Z; Yang L
    Mol Med Rep; 2013 Aug; 8(2):345-9. PubMed ID: 23817964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-suppressive microRNA-22 inhibits the transcription of E-box-containing c-Myc target genes by silencing c-Myc binding protein.
    Xiong J; Du Q; Liang Z
    Oncogene; 2010 Sep; 29(35):4980-8. PubMed ID: 20562918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel PTEN/mutant p53/c-Myc/Bcl-XL axis mediates context-dependent oncogenic effects of PTEN with implications for cancer prognosis and therapy.
    Huang X; Zhang Y; Tang Y; Butler N; Kim J; Guessous F; Schiff D; Mandell J; Abounader R
    Neoplasia; 2013 Aug; 15(8):952-65. PubMed ID: 23908595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pten and p53 converge on c-Myc to control differentiation, self-renewal, and transformation of normal and neoplastic stem cells in glioblastoma.
    Zheng H; Ying H; Yan H; Kimmelman AC; Hiller DJ; Chen AJ; Perry SR; Tonon G; Chu GC; Ding Z; Stommel JM; Dunn KL; Wiedemeyer R; You MJ; Brennan C; Wang YA; Ligon KL; Wong WH; Chin L; dePinho RA
    Cold Spring Harb Symp Quant Biol; 2008; 73():427-37. PubMed ID: 19150964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA miR-183 functions as an oncogene by targeting the transcription factor EGR1 and promoting tumor cell migration.
    Sarver AL; Li L; Subramanian S
    Cancer Res; 2010 Dec; 70(23):9570-80. PubMed ID: 21118966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-410 regulates MET to influence the proliferation and invasion of glioma.
    Chen L; Zhang J; Feng Y; Li R; Sun X; Du W; Piao X; Wang H; Yang D; Sun Y; Li X; Jiang T; Kang C; Li Y; Jiang C
    Int J Biochem Cell Biol; 2012 Nov; 44(11):1711-7. PubMed ID: 22750473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-26a enhances metastasis potential of lung cancer cells via AKT pathway by targeting PTEN.
    Liu B; Wu X; Liu B; Wang C; Liu Y; Zhou Q; Xu K
    Biochim Biophys Acta; 2012 Nov; 1822(11):1692-704. PubMed ID: 22885155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-26a promotes neurite outgrowth by repressing PTEN expression.
    Li B; Sun H
    Mol Med Rep; 2013 Aug; 8(2):676-80. PubMed ID: 23783805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.